In 2013, the first government-led oral cholera vaccination (OCV) campaign in Haiti was implemented in Petite Anse and Cerca Carvajal. To evaluate vaccination coverage, barriers to vaccination, and adverse events following vaccination, we conducted a cluster survey. We enrolled 1,121 persons from Petite Anse and 809 persons from Cerca Carvajal, categorized by 3 age groups (1–4, 5–14, >15 years). Two-dose OCV coverage was 62.5% in Petite Anse and 76.8% in Cerca Carvajal. Two-dose coverage was lowest among persons >15 years of age. In Cerca Carvajal, coverage was significantly lower for male than female respondents (69% vs. 85%; p<0.001). No major adverse events were reported. The main reason for nonvaccination was absence during the campaign. Vaccination coverage after this campaign was acceptable and comparable to that resulting from campaigns implemented by nongovernmental organizations. Future campaigns should be tailored to reach adults who are not available during daytime hours.
Ahead of Print -Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 20131 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Wednesday, April 29, 2015
Ahead of Print -Extensively Drug-Resistant New Delhi Metallo-β-Lactamase–Encoding Bacteria in the Environment, Dhaka, Bangladesh, 2012 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Carriage of the New Delhi metallo-β-lactamase variant 1 (NDM-1) enables drug resistance to move between communities and hospitals. In Bangladesh, we found the blaNDM-1 gene in 62% of environmental waters and in fermentative and nonfermentative gram-negative bacteria. Escherichia coli sequence type (ST) 101 was most commonly found, reflecting a common global relationship between ST101 and NDM-1.
Ahead of Print -Extensively Drug-Resistant New Delhi Metallo-β-Lactamase–Encoding Bacteria in the Environment, Dhaka, Bangladesh, 2012 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Extensively Drug-Resistant New Delhi Metallo-β-Lactamase–Encoding Bacteria in the Environment, Dhaka, Bangladesh, 2012 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Mycobacterium bovis in Panama, 2013 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Panama remains free of zoonotic tuberculosis caused by Mycobacterium bovis. However, DNA fingerprinting of 7 M. bovis isolates from a 2013 bovine tuberculosis outbreak indicated minimal homology with strains previously circulating in Panama. M. bovis dispersion into Panama highlights the need for enhanced genotype testing to track zoonotic infections.
Ahead of Print -Mycobacterium bovis in Panama, 2013 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Mycobacterium bovis in Panama, 2013 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -European Rabbits as Reservoir for Coxiella burnetii - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
We studied the role of European rabbits (Oryctolagus cuniculus) as a reservoir for Coxiella burnetii in the Iberian region. High individual and population seroprevalences observed in wild and farmed rabbits, evidence of systemic infections, and vaginal shedding support the reservoir role of the European rabbit forC. burnetii.
Ahead of Print -European Rabbits as Reservoir for Coxiella burnetii - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -European Rabbits as Reservoir for Coxiella burnetii - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Oligoarthritis Caused by Borrelia bavariensis, Austria, 2014 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
A case of Lyme oligoarthritis occurred in an 11-year-old boy in Vienna, Austria. DNA of Borrelia bavariensis was detected by PCR in 2 aspirates obtained from different joints. Complete recovery was achieved after a 4-week course with amoxicillin. Lyme arthritis must be considered in patients from Europe who have persisting joint effusions.
Ahead of Print -Oligoarthritis Caused by Borrelia bavariensis, Austria, 2014 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Oligoarthritis Caused by Borrelia bavariensis, Austria, 2014 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Data from a large multicenter observational study of patients with multidrug-resistant tuberculosis (MDR TB) were analyzed to simulate the possible use of 2 new approaches to treatment of MDR TB: a short (9-month) regimen and a bedaquiline-containing regimen. Of 1,254 patients, 952 (75.9%) had no resistance to fluoroquinolones and second-line injectable drugs and thus would qualify as candidates for the 9-month regimen; 302 (24.1%) patients with resistance to a fluoroquinolone or second-line injectable drug would qualify as candidates for a bedaquiline-containing regimen in accordance with published guidelines. Among candidates for the 9-month regimen, standardized drug-susceptibility tests demonstrated susceptibility to a median of 5 (interquartile range 5–6) drugs. Among candidates for bedaquiline, drug-susceptibility tests demonstrated susceptibility to a median of 3 (interquartile range 2–4) drugs; 26% retained susceptibility to <2 drugs. These data may assist national TB programs in planning to implement new drugs and drug regimens.
Ahead of Print -Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Endemic Melioidosis in Residents of Desert Region after Atypically Intense Rainfall in Central Australia, 2011 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
After heavy rains and flooding during early 2011 in the normally arid interior of Australia, melioidosis was diagnosed in 6 persons over a 4-month period. Although the precise global distribution of the causal bacterium Burkholderia pseudomallei remains to be determined, this organism can clearly survive in harsh and even desert environments outside the wet tropics.
Ahead of Print -Endemic Melioidosis in Residents of Desert Region after Atypically Intense Rainfall in Central Australia, 2011 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Ahead of Print -Endemic Melioidosis in Residents of Desert Region after Atypically Intense Rainfall in Central Australia, 2011 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Tuesday, April 28, 2015
Monday, April 27, 2015
Thursday, April 23, 2015
Jeni's Ice Cream recalls all products for listeria risk - Apr. 23, 2015
Another ice cream maker pulled all of its products off shelves and halted sales on Thursday because of a listeria risk.
Jeni's Splendid Ice Creams said that it was recalling all of its ice creams, sorbets, and ice cream sandwiches and closing all of its shops for now.
Jeni's Ice Cream recalls all products for listeria risk - Apr. 23, 2015
Jeni's Splendid Ice Creams said that it was recalling all of its ice creams, sorbets, and ice cream sandwiches and closing all of its shops for now.
Jeni's Ice Cream recalls all products for listeria risk - Apr. 23, 2015
Wednesday, April 22, 2015
Tuesday, April 21, 2015
Blue Bell recalls all of its products | Local News - KMBC Home
ce cream, frozen yogurt, sherbert and frozen snacks pulled from shelves
Blue Bell recalls all of its products | Local News - KMBC Home
Monday, April 20, 2015
Thursday, April 16, 2015
Canine flu outbreak sickens hundreds of dogs in Midwest - KCTV5
KANSAS CITY, MO (KCTV/AP) -
Read more: http://www.kctv5.com/story/28818702/canine-flu-outbreak-sickens-hundreds-of-dogs-in-midwest#ixzz3XToj1X00
Canine flu outbreak sickens hundreds of dogs in Midwest - KCTV5
A canine flu outbreak has sickened many dogs in the Midwest, and veterinarians are cautioning pet owners to keep their dogs from going nose-to-nose with other four-legged friends.
A trip to the dog park is usually a wonderful experience for man's best friend. But veterinarians said it might be one of the places to avoid because of the new outbreak. That cough, fever and sluggishness are the first symptoms of a dangerous strain of dog flu.
Read more: http://www.kctv5.com/story/28818702/canine-flu-outbreak-sickens-hundreds-of-dogs-in-midwest#ixzz3XToj1X00
Canine flu outbreak sickens hundreds of dogs in Midwest - KCTV5
Wednesday, April 15, 2015
Stomach bug hits passengers on two Fort Lauderdale-bound ships | Miami Herald Miami Herald
A pair of ships that left Fort Lauderdale in late March for a 15-night Panama Canal voyage got thorough scrubdowns in San Diego this week after dozens of passengers on each came down with a stomach bug.
Both ships — Celebrity Infinity and Royal Caribbean International's Legend of the Seas — are owned by Royal Caribbean Cruises, which is based in Miami.
Stomach bug hits passengers on two Fort Lauderdale-bound ships | Miami Herald Miami Herald
Tuesday, April 14, 2015
Do You Know the Biosecurity Steps to Protect Your Poultry from Avian Influenza? Get Advice From the Experts with #chickenchat2015 on April 16
From the USDA:
Since December 2014, USDA has confirmed several cases of highly pathogenic avian influenza (HPAI) H5 in the Pacific, Central, and Mississippi flyways (or migratory bird paths). The disease has been found in wild birds, as well as in a few backyard and commercial poultry flocks. The Centers for Disease Control and Prevention (CDC) considers the risk to people from these HPAI H5 infections to be low. No human cases of these HPAI H5 viruses have been detected in the United States, Canada, or internationally.
Anyone who owns or works with poultry—whether on a commercial farm, in the wild, or at a hobby/backyard farm—should take proper steps to keep HPAI from spreading. The best way to protect your birds is to follow good biosecurity. Even if you are already familiar with biosecurity, now is a good time to double-check your practices. You are the best protection your birds have!
Be sure to join Dr. Catherine Woteki, USDA Under Secretary for Research, Education and Economics, and others for a Twitter chat aimed to empower poultry owners with the information they need to protect their birds’ health. Participants include: USDA’s Animal and Plant Health Inspection Service, the National Institute of Food and Agriculture, and Forest Service; the United States Geological Survey; the Food and Drug Administration; Department of Agriculture representatives from Delaware, Georgia, Illinois, New Jersey, Pennsylvania, Tennessee and Wisconsin; the National Turkey Federation; and the National Chicken Council. Andy Schneider, a backyard poultry expert, also will be joining the chat, along with Healthy Harry, the spokesbird for USDA’s Biosecurity for Birds outreach campaign.
Tune into @scienceatUSDA or @USDA_APHIS and follow along with #chickenchat2015 on Thursday, April 16 at 2 p.m. EDT (11 a.m. PT) to learn how YOU can protect your poultry from this virus.
As part of its safeguarding mission, the USDA helps protects the health of our Nation’s livestock and poultry. We respond to major animal disease events, helping to keep dangerous diseases from spreading. We also work to reduce the economic impact of disease events.
Saturday, April 11, 2015
Wednesday, April 8, 2015
Tuesday, April 7, 2015
Sunday, April 5, 2015
GSK to establish global vaccines R&D centre in the US
From GSK:
GSK to establish global vaccines R&D centre in the US
02 April 2015
Issued: London and Philadelphia, PA
New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint
GSK announced today it is further strengthening and expanding its vaccines presence in the US by establishing a new global centre for vaccines research and development (R&D) in Rockville, Maryland. The site will become one of three global vaccines R&D centres for GSK, complementing the company’s existing global R&D centres in Rixensart, Belgium and in Siena, Italy, a site which GSK recently acquired from Novartis in March 2015.
The new US vaccines R&D centre will expand GSK’s efforts to discover and develop novel vaccines across a range of pressing public health threats, including those relevant to the US. It will consolidate vaccines R&D activities currently conducted at other GSK sites including in Philadelphia, PA and Cambridge, MA, into one centralised location. Key late stage development programmes, as well as vaccine discovery and new platform technology development will be led from Rockville.
The Rockville site, which was acquired by GSK in 2012, offers proximity to vaccines collaborators and key public health stakeholders. GSK anticipates site operations for vaccines to begin in Rockville as early as September 2015.
Luc Debruyne, President, GSK Vaccines, said: “As the global vaccines leader, GSK is on the cutting edge of vaccine development. Following the acquisition of Novartis’s global vaccines business and in recognition of the vaccines knowledge and expertise in the United States, we are pleased to expand our US presence with the creation of a world-class vaccines R&D centre. This will drive innovation, and enhance our capabilities for new vaccine discoveries that protect the US and public health around the world.”
Maryland Governor Larry Hogan said: “I am proud that a world-class pharmaceutical company like GSK has chosen to grow its US operations in Maryland. With key federal labs like the Food and Drug Administration and the National Institutes of Health in our backyard, a highly-educated workforce and a critical mass of life sciences companies, Maryland offers GSK an excellent environment in which to grow and thrive.”
This move follows GSK’s acquisition of Novartis’ vaccines business as part of the companies’ major three-part transaction that closed in March 2015. GSK and Novartis’s vaccines R&D organisations are highly complementary, bringing together respective expertise in virology and bacterial infection.
GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.
Friday, April 3, 2015
Thursday, April 2, 2015
USGS Release: New Technology Helps Identify Dispersal of Avian Flu Virus between Asia and Alaska (3/31/2015 1:00:00 PM)
ANCHORAGE, Alaska — In a new study published today, scientists from the U.S. Geological Survey and U.S. Fish and Wildlife Service harnessed a new type of DNA technology to investigate avian influenza viruses in Alaska. Using a “next generation” sequencing approach, which identifies gene sequences of interest more rapidly and more completely than by traditional techniques, scientists identified low pathogenic avian influenza viruses in Alaska that are nearly identical to viruses found in China and South Korea.
The viruses were found in an area of western Alaska that is known to be a hot spot for both American and Eurasian forms of avian influenza.
USGS Release: New Technology Helps Identify Dispersal of Avian Flu Virus between Asia and Alaska (3/31/2015 1:00:00 PM)
Subscribe to:
Comments (Atom)